Songklanagarind hospital

Hat Yai, Changwat Songkhla 90110

1 studies enrolling now · 9 studies all time

What they study most

Adjuvant, Branch Retinal Vein Occlusion, Cancer of the Prostate, Carcinoma, Non-Small-Cell Lung, Cardiovascular Risk, Central Retinal Vein Occlusion, Chronic Kidney Disease, Diabetic Macular Edema, EGFR, Early Stage Lung Cancer, Exon 20, First Line Non-Small Cell Lung Cancer

Studies at this site

• A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4) — Recruiting now
• ZEUS - A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Cardiovascular Disease, Chronic Kidney Disease and Inflammation — Completed
• A Research Study to Look at How Ziltivekimab Works Compared to Placebo in People With Heart Failure and Inflammation — Running, not enrolling
• A Study to Assess the Efficacy and Safety of Zipalertinib Versus Placebo for Adjuvant Treatment in Participants With Stage IB-IIIA NSCLC With Uncommon EGFR Mutations, Following Complete Tumor Resection — Running, not enrolling
• A Real-World Study to Gain Clinical Insights Into Roche Ophthalmology Products — Running, not enrolling
• Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer — Completed
• DISSECT-N Post Market Data Collection Registry — Completed
• Avelumab in First-line NSCLC (JAVELIN Lung 100) — Completed
• Phase 3 Study of ThermoDox With Radiofrequency Ablation (RFA) in Treatment of Hepatocellular Carcinoma (HCC) — Completed